Immune-related adverse events and the balancing act of immunotherapy

被引：0

作者：

Michael Conroy

Jarushka Naidoo

机构：

[1] Beaumont RCSI Cancer Centre,

[2] Beaumont Hospital,undefined

[3] RCSI University of Health Sciences,undefined

[4] Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins University,undefined

来源：

Nature Communications | / 13卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The benefit from immune checkpoint inhibitors is tempered by immunologic toxicities, which involve diverse organs, have varying biology, onset time, and severity. Herein, we identify important areas of controversy and open research questions in the field of immune-related toxicity.

引用